Related Experiment Video
Updated: Jun 2, 2026

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases
Published on: October 24, 2019
Bibliometric data in clinical cardiology revisited. The case of 37 Dutch professors
1Department of Clinical and Experimental Cardiology, Heart Failure Research Center, Academic Medical Center, Meibergdreef 9, Room K2-105, 1105 AZ, Amsterdam, the Netherlands, t.opthof@inter.nl.net.
Insights
Bibliometric parameters like the Hirsch index (h-index) are inconsistent for evaluating clinical cardiology professors. Current citation metrics lack reliability for science policy, especially across different medical fields.
Area of Science:
- Cardiology
- Bibliometrics
- Scientometrics
Background:
- Bibliometric indicators are increasingly used in academic evaluation and science policy.
- The Hirsch index (h-index) is a common metric, but its suitability for diverse scientific fields remains debated.
- Assessing the utility of bibliometric parameters within specialized medical fields is crucial.
Purpose of the Study:
- To evaluate the bibliometric performance of 37 Dutch professors in clinical cardiology.
- To determine the consistency of various bibliometric parameters (h-index, first-authored h-index, paper count, citation count, citations per paper) in ranking these experts.
- To assess the suitability of current bibliometric parameters for science policy decisions in medicine.
Main Methods:
- Compilation of bibliometric data for 37 Dutch clinical cardiology professors.
- Calculation of five key parameters: overall h-index, first-authored h-index, total publications, total citations, and average citations per paper.
- Generation of top 10 lists for each parameter to compare the consistency of rankings.
Main Results:
- Only 22 out of 37 professors appeared in at least one of the five top 10 lists, indicating significant parameter variability.
- No single bibliometric parameter consistently identified the same group of leading professors.
- Considerable inhomogeneity in citation characteristics was observed even within this specialized group.
Conclusions:
- Current bibliometric parameters are not sufficiently robust or reliable for evaluating individual scientists or informing science policy, particularly in specialized medical fields.
- The observed increase in publications per author may reflect increased collaboration and network effects rather than genuine productivity gains.
- Citation analysis requires cautious application, especially when comparing diverse medical disciplines within academic institutions.
Abstract:
In this paper, we assess the bibliometric parameters of 37 Dutch professors in clinical cardiology. Those are the Hirsch index (h-index) based on all papers, the h-index based on first authored papers, the number of papers, the number of citations and the citations per paper. A top 10 for each of the five parameters was compiled. In theory, the same 10 professors might appear in each of these top 10s. Alternatively, each of the 37 professors under assessment could appear one or more times. In practice, we found 22 out of these 37 professors in the 5 top 10s. Thus, there is no golden parameter. In addition, there is too much inhomogeneity in citation characteristics even within a relatively homogeneous group of clinical cardiologists. Therefore, citation analysis should be applied with great care in science policy. This is even more important when different fields of medicine are compared in university medical centres. It may be possible to develop better parameters in the future, but the present ones are simply not good enough. Also, we observed a quite remarkable explosion of publications per author which can, paradoxical as it may sound, probably not be interpreted as an increase in productivity of scientists, but as the effect of an increase in the number of co-authors and the strategic effect of networks.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
Clinical Trials: Overview
Acute Coronary Syndrome III: Diagnostic Studies
Pathophysiology of Cardiac Performance
